Iowa City, IOWA2 Active Studies

Duchenne Muscular Dystrophy Clinical Trials in Iowa City, IOWA

Find 2 actively recruiting duchenne muscular dystrophy clinical trials in Iowa City, IOWA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
265
Enrolling

Recruiting Duchenne Muscular Dystrophy Studies in Iowa City

About Duchenne Muscular Dystrophy Clinical Trials in Iowa City

Duchenne muscular dystrophy is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. It is caused by mutations in the dystrophin gene. Treatment includes corticosteroids, gene therapies, and supportive care to maintain mobility and function.

There are currently 2 duchenne muscular dystrophy clinical trials recruiting participants in Iowa City, IOWA. These studies are seeking a combined 265 participants. Research is being sponsored by Avidity Biosciences, Inc., REGENXBIO Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Duchenne Muscular Dystrophy Clinical Trials in Iowa City — FAQ

Are there duchenne muscular dystrophy clinical trials in Iowa City?

Yes, there are 2 duchenne muscular dystrophy clinical trials currently recruiting in Iowa City, IOWA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Iowa City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.

Are clinical trials in Iowa City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.

What duchenne muscular dystrophy treatments are being tested?

The 2 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for duchenne muscular dystrophy.

Data updated March 2, 2026 from ClinicalTrials.gov